Thursday, October 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career

DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 09:43 ETSource: STAT

From the source

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists.

Read at statnews.com
PeptiPrescribed peptides from $99/moSee all →